Fact CheckerSign in

NCT06010030Active, not recruiting

HD-tDCS for Phonological Impairment in Aphasia

A Randomized Clinical Trial of tDCS to Remediate Phonological Impairment in Aphasia

Source: ClinicalTrials.gov · Last updated 13 Mar 2026

Brief summary (registry, in English)

This study will investigate the effects of mild electrical stimulation in conjunction with speech therapy for people with post-stroke aphasia to enhance language recovery.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
200 (estimated)
First submitted
18 Aug 2023
Start date
3 Oct 2023
Primary completion date
1 Jan 2033
Lead sponsor
Medical College of Wisconsin
Diseases
Stroke
NCT number
NCT06010030

What you commit to

  • Study type: Interventional
  • Planned participants: 200
  • From 3 Oct 2023 to the primary completion date, 1 Jan 2033
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • Advanced neurodegenerative disease (i.e. Stage 3 Alzheimer's disease)
    • Neurologic disease (e.g. idiopathic epilepsy, seizure disorders that are not well managed, Parkinson's disease, ALS),
    • Severe psychopathology (e.g. schizophrenia, bipolar disorder, acute major depressive episode)
    • Suspected or diagnosed uncorrectable hearing or vision difficulties, or developmental disabilities (i.e. intellectual disability or learning disability).
    • Contraindications to MRI such as claustrophobia, implanted electronic devices, MRI-incompatible metal in the body, extreme obesity, pregnancy, inability to lie flat, inability to see or hear stimulus materials.
    • Younger than 18 or older than 85.
    • \< 6 months post tumor resection.

Who the study is looking for

  • Patients must be 18 or older.
    • Patients may not be older than 85.
    • Patients must have a language deficit from left-sided focal neurologic damage (e.g. stroke, tumor).
    • Patients must be adults and have English-language fluency.
    • Patients must be eligible to undergo MRI.
    • Beyond meeting the inclusion criteria, no preference will be given on the basis of race, ethnicity or gender.

Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Medical College of Wisconsin
Coordinator of this site? Confirm its status
MilwaukeeUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.